NCT06705088View on ClinicalTrials.gov

Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SUVN-I6107 In Healthy Participants

PHASE1RecruitingINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

January 7, 2025

Primary Completion Date

October 13, 2025

Study Completion Date

October 13, 2025

Conditions
Healthy
Interventions
DRUG

SUVN-I6107

SUVN-I6107 Tablet

DRUG

Placebo

A look-alike tablet with no active ingredient.

Trial Locations (1)

78209

RECRUITING

Clinical Research Site, San Antonio

All Listed Sponsors
lead

Suven Life Sciences Limited

INDUSTRY